Possibility Care Well being (NYSE: OPCH), the supplier of infusion providers at residence and different places, had an amazing 2023. However about six months faraway from its failed try to purchase Amedisys Inc. (Nasdaq: AMED), it nonetheless stays a house care supplier price taking note of.

On Tuesday, the corporate's leaders laid out their technique for the longer term on the JP Morgan Healthcare Convention. They haven’t dismissed future mergers and acquisitions within the residence care discipline both, however they’ve made some vital caveats.

In October, John C. Rademacher, CEO of Possibility Care Well being, defined that residence well being and hospice have been distinctive service strains that will have created an “end-to-end continuum” within the residence for the corporate.

But he additionally defined that Amedisys was the apple of the corporate's eye, not simply residence care and hospice typically.

“We actually thought the Amedisys was distinctive in its capabilities,” Rademacher mentioned. “Definitely due to the attain, within the star scores, in addition to a few of the further capabilities with Contessa Well being and another facets of that. So not all residence care assets are equal in that regard.”

Possibility Care Well being, based mostly in Bannockburn, Illinois, is without doubt one of the largest unbiased suppliers of residence and different web site infusion providers. It gives these providers in all 50 states, with greater than 7,500 crew members and 4,500 physicians beneath its umbrella.

Possibility Care Well being agreed to amass Amedisys – one of many nation's largest residence well being and hospice corporations – in Might of final yr. In June, UnitedHealth Group's Optum lured away Amedisys with a superior money supply for Amedisys. That deal continues to be pending.

CFO Mike Shapiro defined Tuesday that there are nonetheless acquisition alternatives, however the firm just isn’t searching for a splashy “M&A headline.”

“The excellent news is that we’re able the place we as soon as once more have a really robust performing base enterprise,” Shapiro mentioned. “We don't really feel the stress. Of all of the issues John and I take into consideration, getting an M&A headline isn't certainly one of them. And so we now have the flexibility to be very affected person and considerate.

Rademacher added that Possibility Care Well being “discovered loads from the Amedisys train.”

“We see some very engaging alternatives on the M&A entrance that we consider might be each strategic and compelling [economically],” he mentioned.

Each Rademacher and Shapiro appeared to counsel that extra mergers and acquisitions have been on the best way for the corporate within the close to future.

“The excellent news is that this isn't a giant neighborhood,” Shapiro mentioned. “We all know the folks dwelling on the streets, we all know the suppliers and the property which might be engaging. And we don't simply look forward to a banker to ring our doorbell, we proactively correspond with folks we predict would make a lovely mixture. There may be extra to come back on this entrance.”